Downloadable Slideset


Share

Program Content

Activities

  • CD38 in MM
    Rationale for Targeting CD38, Disparities in Care, and Treatment Implications in Newly Diagnosed MM
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 10, 2024

    Expires: June 09, 2025

  • Quad Tx in ASCT Eligible NDMM
    The Impact of Quadruplet Therapy Incorporating CD38 Antibodies in Transplant-Eligible Patients With NDMM
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 11, 2024

    Expires: June 10, 2025

  • CD38 mAb in ASCT Ineligible NDMM
    Optimizing Clinical Outcomes With CD38 Antibodies for Transplant-Ineligible Patients With NDMM
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 11, 2024

    Expires: June 10, 2025

Faculty

cover img faculity

Michele Cavo, MD

Head, “Seràgnoli” Institute of Hematology
Director, Postgraduate Residency in Hematology
Full Professor of Hematology
Department of Medical and Surgical Sciences
Bologna University School of Medicine
Bologna, Italy

cover img faculity

Francesca Gay, MD, PhD

Associate Professor
Department of Molecular Biotechnology and Health Science
University of Torino
SC Ematologia 1
AOU Citta della Salute e della Scienza
Torino, Italy

cover img faculity

Paul G. Richardson, MD

Director of Clinical Research
Clinical Program Leader
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi